Year |
Citation |
Score |
2006 |
Vukmirica J, Monzo P, Le Marchand-Brustel Y, Cormont M. The Rab4A effector protein Rabip4 is involved in migration of NIH 3T3 fibroblasts. The Journal of Biological Chemistry. 281: 36360-8. PMID 17001082 DOI: 10.1074/jbc.M602920200 |
0.304 |
|
2003 |
Vukmirica J, Tran K, Liang X, Shan J, Yuan J, Miskie BA, Hegele RA, Resh MD, Yao Z. Assembly and secretion of very low density lipoproteins containing apolipoprotein B48 in transfected McA-RH7777 cells. Lack of evidence that palmitoylation of apolipoprotein B48 is required for lipoprotein secretion. The Journal of Biological Chemistry. 278: 14153-61. PMID 12582154 DOI: 10.1074/jbc.M211995200 |
0.522 |
|
2002 |
Vukmirica J, Nishimaki-Mogami T, Tran K, Shan J, McLeod RS, Yuan J, Yao Z. The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL. Journal of Lipid Research. 43: 1496-507. PMID 12235182 DOI: 10.1194/Jlr.M200077-Jlr200 |
0.465 |
|
2001 |
Ko KW, Avramoglu RK, McLeod RS, Vukmirica J, Yao Z. The insulin-stimulated cell surface presentation of low density lipoprotein receptor-related protein in 3T3-L1 adipocytes is sensitive to phosphatidylinositide 3-kinase inhibition. Biochemistry. 40: 752-9. PMID 11170392 DOI: 10.1021/Bi001797+ |
0.431 |
|
1999 |
Raffaï R, Vukmirica J, Weisgraber KH, Rassart E, Innerarity TL, Milne R. Bacterial expression and purification of the Fab fragment of a monoclonal antibody specific for the low-density lipoprotein receptor-binding site of human apolipoprotein E. Protein Expression and Purification. 16: 84-90. PMID 10336864 DOI: 10.1006/Prep.1999.1031 |
0.309 |
|
1998 |
Ko KW, McLeod RS, Avramoglu RK, Nimpf J, FitzGerald DJ, Vukmirica J, Yao Z. Mutation at the processing site of chicken low density lipoprotein receptor-related protein impairs efficient endoplasmic reticulum exit, but proteolytic cleavage is not essential for its endocytic functions. The Journal of Biological Chemistry. 273: 27779-85. PMID 9774386 DOI: 10.1074/jbc.273.43.27779 |
0.496 |
|
Low-probability matches (unlikely to be authored by this person) |
2017 |
Sorli C, Harris S, Jódar E, Lingvay I, Vukmirica J, Chandarana K, Langer J, Jaeckel E. IDegLira is Efficacious Across Baseline HbA1C Categories in Subjects with Type 2 Diabetes Uncontrolled on SU, GLP-1RA or Insulin Glargine: Analyses from Completed Phase 3b Trials Canadian Journal of Diabetes. 41: S58. DOI: 10.1016/J.JCJD.2017.08.157 |
0.134 |
|
2017 |
Harris S, Jaeckel E, Jódar E, Lingvay I, Vukmirica J, Chandarana K, Abrahamsen TJ, Sorli C. Impact of BMI on HbA1C Reduction in Response to IDegLira in Subjects with Type 2 Diabetes (T2D) Uncontrolled on SU, GLP-1RA or Insulin Glargine: Analyses from Completed Phase 3b Trials Canadian Journal of Diabetes. 41: S58. DOI: 10.1016/J.JCJD.2017.08.158 |
0.129 |
|
2013 |
Garber AJ, Evans M, Christensen T, Korsholm L, Vukmirica J, Brod M. Impact of Severe Hypoglycemia on Health-Related Quality of Life (HRQoL) in Insulin-Treated Patients with Type 1 and Type 2 Diabetes Canadian Journal of Diabetes. 37: S53. DOI: 10.1016/j.jcjd.2013.08.157 |
0.129 |
|
2010 |
Radosavljevic J, Dobrijevic D, Jadranin M, Blanusa M, Vukmirica J, Cirkovic Velickovic T. Insights into proteolytic processing of the major peanut allergen Ara h 2 by endogenous peanut proteases. Journal of the Science of Food and Agriculture. 90: 1702-8. PMID 20564442 DOI: 10.1002/jsfa.4005 |
0.088 |
|
2016 |
Lau D, Astrup A, Fujioka K, Greenway F, Roux CL, Gaal LA, Ortiz RV, Wilding J, Skjoth T, Manning LS, Vukmirica J, Pi-Sunyer X. Reduction in the Risk of Developing Type 2 Diabetes (T2D) with Liraglutide 3.0 mg in People with Prediabetes from the SCALE Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled Trial Canadian Journal of Diabetes. 40: S34. DOI: 10.1016/J.JCJD.2016.08.100 |
0.048 |
|
2012 |
Ognjenović J, Tantoush ZO, Jankov R, Veličković TC, Vukmirica J. Isolation of functional total RNA from Tilia cordata leaves and pollen Journal of the Serbian Chemical Society. 77: 1003-1012. DOI: 10.2298/JSC111130018O |
0.035 |
|
2017 |
Vukmirica J, Hramiak I, Rodbard HW, Bellary S, Seino Y, Silver R, Bergan E, Birch S, Aroda V. Responder Analysis of Subjects Achieving HbA1c ≥1% and Weight Loss ≥5% Across SUSTAIN 1–5 Clinical Trials Canadian Journal of Diabetes. 41: S5-S6. DOI: 10.1016/j.jcjd.2017.08.019 |
0.02 |
|
Hide low-probability matches. |